Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Longeveron Inc.
- Processa Pharmaceuticals, Inc.
Updated Jul 16, 2026
Baluch Khoso has filed 1 SEC Form 4 filing across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $6K. Lifetime open-market sales: $3K.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | PCSA | Processa Pharmaceuticals, Inc. | M — Option exercise | 203 | — | |
| 2026-04-01 | PCSA | Processa Pharmaceuticals, Inc. | P — Open-market purchase | 2.3K | $2.54 | $6K |
| 2025-08-11 | LGVN | Longeveron Inc. | P — Open-market purchase | 11.8K | — | |
| 2025-07-15 | LGVN | Longeveron Inc. | A — Grant or award | 17.0K | $0.00 | |
| 2024-12-04 | LGVN | Longeveron Inc. | S — Open-market sale | 1.2K | $2.07 | $3K |
Baluch Khoso is a corporate insider — currently tracked as Insider of Processa Pharmaceuticals, Inc. (PCSA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 3 open-market purchases ($6K) and 1 open-market sales ($3K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Baluch Khoso profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.